# China NMPA Drug Inspection - Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. - Salt-based Psoralea corylifolia

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/chengdu-dujiangyan-chunsheng-traditional-chinese-medicine-pieces-co-ltd/fff5761d-e5b8-4aed-b15a-e3706cf3b08e/
Source feed: China

> China NMPA drug inspection for Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. published April 02, 2018. Drug: Salt-based Psoralea corylifolia. The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on April 2, 2018, 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Tianjin Municipal Drug Quality Bulletin (Issue 1, 2018, Serial No. 32)
- Company Name: Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2018-04-02
- Drug Name: Salt-based Psoralea corylifolia
- Inspection Finding: Non-compliant: Content determination
- Action Taken: Market regulatory law enforcement departments at all levels promptly investigated and dealt with the unqualified drug according to law.
- Summary: The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on April 2, 2018, following supervision and sampling inspections aimed at ensuring drug quality and public safety. These inspections identified three batches of drugs that failed to meet established standards. Specifically, Anguo Changda Traditional Chinese Medicine Decoction Pieces Co., Ltd. had a batch of Amomum villosum deemed substandard due to failing the Borneol Acetate content determination, as per the Chinese Pharmacopoeia 2010 Edition. Chengdu Dujiangyan Chunsheng Traditional Chinese Medicine Pieces Co., Ltd. had a batch of Salt-processed Psoralea corylifolia found unqualified against the Chinese Pharmacopoeia 2015 Edition, also related to content determination. Lastly, Dalian Quanjian Traditional Chinese Medicine Pieces Co., Ltd. produced a batch of Alum that was unqualified due to an ammonium salt inspection failure, according to the Chinese Pharmacopoeia 2010 Edition. In response, municipal market supervision and law enforcement departments initiated investigations and enforcement actions against the identified substandard drugs. The regulatory framework for these inspections was primarily the Chinese Pharmacopoeia. Moving forward, the Commission plans to intensify supervision and inspection of traditional Chinese medicine decoction pieces and strengthen risk prevention and control measures to continuously uphold drug quality and safeguard public health.

Company: https://www.globalkeysolutions.net/companies/chengdu-dujiangyan-chunsheng-traditional-chinese-medicine-pieces-co-ltd/5554677b-1b4c-4b25-b19c-2903cdc7b0af/